These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24885964)

  • 21. Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells.
    Yang Y; Chan JY; Temiz NA; Yee D
    Horm Cancer; 2018 Dec; 9(6):371-382. PubMed ID: 30229539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response.
    Kiran S; Oddi V; Ramakrishna G
    Exp Cell Res; 2015 Feb; 331(1):123-141. PubMed ID: 25445786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylinositol 3-kinase and protein kinase D1 specifically cooperate to negatively regulate the insulin-like growth factor signaling pathway.
    Karam M; Lassarre C; Legay C; Ricort JM
    Biochim Biophys Acta; 2012 Feb; 1823(2):558-69. PubMed ID: 22227580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.
    Jackson JG; Yee D
    Growth Horm IGF Res; 1999 Oct; 9(5):280-9. PubMed ID: 10543935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells.
    Chan JY; LaPara K; Yee D
    Oncogene; 2016 Aug; 35(32):4235-43. PubMed ID: 26876199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.
    del Rincón SV; Rousseau C; Samanta R; Miller WH
    Oncogene; 2003 May; 22(22):3353-60. PubMed ID: 12776186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
    Jackson JG; White MF; Yee D
    J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells.
    Chen WF; Wong MS
    J Clin Endocrinol Metab; 2004 May; 89(5):2351-9. PubMed ID: 15126563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
    Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R
    PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer.
    Yang F; Hu Y; Shao L; Zhuang J; Huo Q; He S; Chen S; Wang J; Xie N
    Cell Oncol (Dordr); 2021 Dec; 44(6):1405-1424. PubMed ID: 34797559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
    Fox EM; Miller TW; Balko JM; Kuba MG; Sánchez V; Smith RA; Liu S; González-Angulo AM; Mills GB; Ye F; Shyr Y; Manning HC; Buck E; Arteaga CL
    Cancer Res; 2011 Nov; 71(21):6773-84. PubMed ID: 21908557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).
    Lu Y; Zi X; Zhao Y; Mascarenhas D; Pollak M
    J Natl Cancer Inst; 2001 Dec; 93(24):1852-7. PubMed ID: 11752009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.
    Hua H; Kong Q; Yin J; Zhang J; Jiang Y
    J Hematol Oncol; 2020 Jun; 13(1):64. PubMed ID: 32493414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins.
    Fottner C; Engelhardt D; Weber MM
    J Endocrinol; 1998 Sep; 158(3):409-17. PubMed ID: 9846170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction.
    Salahifar H; Baxter RC; Martin JL
    Endocrinology; 1997 Apr; 138(4):1683-90. PubMed ID: 9075731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.